Atlas Trials

Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients With Lynch Syndrome

Clinical trial NCT02052908 · COMPLETED

Trial details

NCT number
NCT02052908
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Lynch Syndrome
Start date
2014-01-27
Primary completion
2019-10-25
Enrollment
81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.